Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis: a Phase 2, Randomized, Double-blind Study

NCT02644551 is registered in ClinicalTrials.gov with 9305-9954 Quebec Inc as lead sponsor.

NCT NCT02644551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis: a Phase 2, Randomized, Double-blind Study
Lead sponsor
9305-9954 Quebec Inc
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2016
Completion date
September 30, 2018
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis